Omadacycline clinical trials
Also written Nuzyra and PTK 0796.
How each study uses omadacycline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the omadacycline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 2 Oct 2018 · NUZYRA · NDA 209816 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2021 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 7
Paratek Pharmaceuticals Inc (12) · Zai Lab (Hong Kong), Ltd. (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Paul Beringer (1) · University of Houston (1) · Wake Forest University Health Sciences (1) · Hartford Hospital (1) · Vancouver Coastal Health (1)
Often tested with
Tested in the same studies.
Amikacin (1) · Clofazimine (1) · Bedaquiline (1) · Linezolid (1) · Sulfamethoxazole (1) · Trimethoprim (1) · Imipenem (1) · Cilastatin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test omadacycline.
- Jul 2027Omadacycline for Treatment Refractory Mycoplasma Genitalium UrethritisPhase 2 · Montefiore Medical Center
- Oct 2027Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionPhase 1 · Vancouver Coastal Health
Studies
Open first, then newest update. How each study uses omadacycline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 21
- Omadacycline for Treatment Refractory Mycoplasma Genitalium UrethritisNot yet recruitingPhase 2Montefiore Medical CenterNCT07853742Written as Omadacycline Oral TabletHow we know
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationPhase 1Vancouver Coastal HealthNCT07228702Written as Omadacycline Oral TabletHow we know
- A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPRecruitingPhase 3Zai Lab (Hong Kong), Ltd.NCT06162286Written as OmadacyclineHow we know
- Pharmacokinetics of Omadacycline in Cystic FibrosisCompletedPhase 4Paul BeringerNCT04460586Written as Omadacycline Injection [Nuzyra]How we know
- Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial InfectionsCompletedPhase 1Paratek Pharmaceuticals IncNCT05217537Written as Omadacycline Injection [Nuzyra]How we know
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint InfectionActive, not recruitingPhase 2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT05753215Written as Omadacycline PillHow we know
- Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)CompletedPhase 2Paratek Pharmaceuticals IncNCT04922554Written as Omadacycline Oral TabletHow we know
- Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial PneumoniaCompletedPhase 3Paratek Pharmaceuticals IncNCT04779242Written as OmadacyclineHow we know
- Microbiome Effect of Omadacycline on Healthy VolunteersCompletedPhase 1University of HoustonNCT06030219Written as OmadacyclineHow we know
- Effects of Intravenous (IV) Omadacycline on Gut MicrobiomeCompletedPhase 4Wake Forest University Health SciencesNCT05515562Written as Omadacycline InjectionHow we know
- A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult VolunteersCompletedPhase 1Zai Lab (Hong Kong), Ltd.NCT06462326Written as Omadacycline Oral TabletHow we know
- Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial PneumoniaCompletedPhase 1Paratek Pharmaceuticals IncNCT04160260Written as OmadacyclineHow we know
- Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisCompletedPhase 1Hartford HospitalNCT04144374Written as OmadacyclineHow we know
- Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)TerminatedPhase 3Paratek Pharmaceuticals IncNCT00865280Written as PTK 0796How we know
- Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)CompletedPhase 2Paratek Pharmaceuticals IncNCT03716024Written as PTK 0796How we know
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute PyelonephritisCompletedPhase 2Paratek Pharmaceuticals IncNCT03757234Written as OmadacyclineHow we know
- Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of CystitisCompletedPhase 2Paratek Pharmaceuticals IncNCT03425396Written as Omadacycline tabletsHow we know
- Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)CompletedPhase 3Paratek Pharmaceuticals IncNCT02378480Written as OmadacyclineHow we know
- Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)CompletedPhase 3Paratek Pharmaceuticals IncNCT02531438Written as OmadacyclineHow we know
- Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSICompletedPhase 3Paratek Pharmaceuticals IncNCT02877927Written as OmadacyclineHow we know
Codes
What other systems call omadacycline · ClinicalTrials.gg INT000071
- MeSH (NLM) C000591640omadacyclineOne source NLM
- UNII (FDA) 090IP5RV8FOMADACYCLINEConfirmed FDA, NLM
- RxNorm 2059269One source FDA
- NCI Thesaurus C90688OmadacyclineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000591640 | omadacycline | One source NLM |
| UNII (FDA) | 090IP5RV8F | OMADACYCLINE | Confirmed FDA, NLM |
| RxNorm | 2059269 | — | One source FDA |
| NCI Thesaurus | C90688 | Omadacycline | One source FDA |
Also registered as omadacycline tosylate (UNII 5658Y89YCD · RxNorm 2059268).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.